Healthcare
Hospital Authority to recruit 330 doctors
Hospital Authority to recruit 330 doctors
Secretary for Food & Health Dr. York Chow says the Hospital Authority plans to recruit about 330 doctors in the current fiscal year.
Warning issued against benzocaine products
An alert has been issued on the use of benzocaine products due to its potentially fatal side effect by the Department of Health.
Government tightened drug laws
This is to prevent the abuse of new-trend psychotropic drugs and to hinder the production of ketamine.
Sino Biopharmaceutical 2010 profit up 42.8% to HK$567mn
The company acquires manufacturer of dermatology and hormonal pharmaceutical products to bring new revenue contributions to the Group.
Hong Kong atmosphere, water remain safe
Radiation levels in Hong Kong's air and drinking water remain normal.
Hong Kong safe from Japan's nuclear incident
Hong Kong Observatory has increased its frequency of taking air samples and its release of information on Hong Kong's radiation levels to once every...
Hospital Authority to resolve medical-staff shortages
Dr York Chow, Secretary for Food & Health, urged the Hospital Authority to work with the College of Physicians to find solutions to medical-staff...
Hong Kong signed health pact agreement with Shenzhen
The agreement will enhance co-operation on quarantine and health measures at boundary control points.
HK pharmaceutical market to grow steadily
The Hong Kong pharmaceutical market should reach HKD10.56 billion by 2014, up from the calculated HKD7.19 billion in 2009.
Hua Xia Healthcare posts third quarter profit of HK$43.6mn
The group’s acquisition of Huihao Group has become its significant income stream driver which continues to deliver satisfactory results.
Sino Biopharmaceutical profit up 16.8% to HK$320mln
The company strengthens its quality control and product development to enhance the competitiveness of its products and brand.
MicroPort raises HK$1.5bln in Hong Kong IPO
Proceeds will be used to develop new products, acquire businesses and expand company’s production facilities.
Shanghai Pharma to raise $1.2bln via HK IPO
Company to offer 25% stake to fund acquisition of rivals and sales networks.
Read Here
Advertise
Sign Up
Commentary
Hong Kong OTC derivatives reporting re-write – Are you ready?
Breaking down silos: The key to Hong Kong's urban future